Main description:

This issue of Clinics in Chest Medicine, edited by Dr. Michael Niederman, focuses on Pneumonia, with topics including: Inflammation and Pneumonia; The Lung Microbiome's Role in Pneumonia; Biomarkers for the Management of Pneumonia; Influenza and Viral Pneumonia; Guidelines to Manage Community-Acquired Pneumonia (CAP); Vaccines to Prevent CAP; Adjunctive Therapies for CAP; Healthcare Associated Pneumonia; Rapid Diagnostic Methods for Pneumonia; Airway Devices in VAP Pathogenesis and Prevention; Management of VAP; Distinguishing Ventilator-Associated Tracheobronchitis from VAP; Practical Approaches to VAP Prevention; Optimizing Antibiotic Administration for Pneumonia; New Antibiotics for Pneumonia; and Personalized Approach to Pneumonia Management.

Contents:

Preface

1. INFLAMMATION AND PNEUMONIA: WHY ARE SOME MORE SUSCEPTIBLE THAN OTHERS?

2. THE LUNG MICROBIOME AND ITS ROLE IN PNEUMONIA

3. BIOMARKERS FOR THE MANAGEMENT OF PNEUMONIA

4. NFLUENZA AND VIRAL PNEUMONIA

5. Guidelines to Manage Community-Acquired Pneumonia

6. Vaccines to Prevent Community-Acquired Pneumonia

7. Adjunctive Therapies for Community-Acquired Pneumonia

8. HEALTHCARE ASSOCIATED PNEUMONIA: STILL A USEFUL CONCEPT?

9. AIRWAY DEVICES IN VAP PATHOGENESIS AND PREVENTION

10. MANAGEMENT OF VAP: GUIDELINES

11. HOW CAN WE DISTINGUISH VENTILATOR ASSOCIATED TRACHEOBRONCHITIS FROM VAP?

12. IS ZERO VAP ACHIEVABLE? PRACTICAL APPROACHES TO VAP PREVENTION

13. AEROSOL THERAPY OF PNEUMONIA IN THE ICU

14. Optimizing Antibiotic Administration for Pneumonia

15. New Antibiotics for Pneumonia

16. PERSONALIZED APPROACH TO PNEUMONIA MANAGEMENT